1. Home
  2. /
  3. COA in the News

COA in the News


Jul 19

2019

CMS Proposes New Bundled Payment Model for Radiation Oncology

The Centers for Medicare & Medicaid Services (CMS) has proposed a new payment model for radiation oncology.

Read more

Jul 18

2019

There’s A Battle Brewing Over Who Gets To Sell Chemo Pills For Cancer Treatment

Cancer treatment has never been cheap. But in the pricey world of pharmaceuticals, the cost of oncology drugs has become jaw-dropping. And where there are big dollars, there is a battle between business interests, which is why cancer doctors are declaring war against pharmacy benefit managers.

Read more

Jul 11

2019

HMP’s Oncology Clinical Pathways Congress Partners with the Community Oncology Alliance

HMP, a leader in healthcare events and education, today announced the Community Oncology Alliance (COA) as an official partner of the Oncology Clinical Pathways Congress, taking place October 11-13, 2019 in Boston.

Read more

Jul 2

2019

Strategic Vision and Recognition of High-Quality Care in OCM 2.0

Last month, the Community Oncology Alliance (COA) announced a detailed alternative payment model that includes proposals for value-based contracts that would provide high-quality oncology care at a low cost. Oncology Care Model (OCM) 2.0 was a highly anticipated response on COA’s part to some of the flaws and shortcomings of the Centers for Medicare

Read more

Jun 26

2019

ACHC Links Partnership Renewal with COPA

We strongly value both healthcare advocacy and excellence in patient care at Accreditation Commission for Health Care (ACHC), which is why we're excited to announce the continuation of our partnership with Community Oncology Pharmacy Association (COPA). Matt Hughes, ACHC Director of Business Development, lauded the ongoing collaboration between the organizations via ACHC's Partnership Program.

Read more

Jun 20

2019

The American Journal of Managed Care® Launches ‘Immunotherapy in the Oncology Care Model’

“For the last two years, the CMS Oncology Care Model has been working on increasing the coordination of oncology care,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of AJMC®. “During this informative video series, our panel of key opinion leaders comes together to provide some insight on the five-year

Read more

Jun 19

2019

The Real-Life Patient Impact of Pharmacy Benefit Managers

The Centers for Medicare & Medicaid Services (CMS) recently released a final rule for Medicare Part D that codified its decision to allow Medicare Advantage plans to use step therapy, or “fail first,” for new starts of drugs for cancer and other serious diseases.1

Read more

Jun 19

2019

Two-Sided Risk in the Oncology Care Model

The US healthcare system remains one of the most inefficient healthcare systems in the world. The Bloomberg Health-Care Efficiency Index ranked the United States 54th among 56 countries in 2018, tied with Azerbaijan and only ahead of Bulgaria.1 This occurs even though the United States spends $10,244 per capita annually on healthcare, a figure representing 17%

Read more

Jun 14

2019

Costs at Hospital-Based Oncology Practices Continue to Outpace Those of Community Cancer Clinics

When it comes to the various costs of cancer care, including chemotherapy, immunotherapy, emergency department (ED) visits, outpatient care, daily expenditures, and 6-month expenditures, hospital-based practices continue to be outperformed by community cancer clinics.

Read more

Jun 13

2019

COA Announces APM to Improve Cancer Care and Reduce Costs

The Community Oncology Alliance (COA) announced a detailed alternative payment model that includes proposals for value-based contracts that would provide high-quality, coordinated oncology care at a lower cost.

Read more